O-GlcNAcylation under hypoxic conditions and its effects on the blood-retinal barrier in diabetic retinopathy

Xu,Chong; Liu,Guodong; Liu,Xiaoqiao; Wang,Fang

doi:10.3892/ijmm.2013.1597

O-GlcNAcylation under hypoxic conditions and its effects on the blood-retinal barrier in diabetic retinopathy

Authors:
- Chong Xu
- Guodong Liu
- Xiaoqiao Liu
- Fang Wang
View Affiliations

Affiliations: Department of Ophthalmology, Shanghai Tenth People's Hospital Affiliated to Tongji University School of Medicine, Shanghai 200072, P.R. China
Published online on: December 20, 2013 https://doi.org/10.3892/ijmm.2013.1597
Pages: 624-632

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

An increase in O-linked N-acetylglucosamine (O-GlcNAc) protein modifications has been observerd in db/db mouse retinas. O-GlcNAc-modified proteins in the db/db mouse retina have been shown to be localized in the ganglion cell layer, the inner nuclear layer, the retina pigment epithelium (RPE) layer and the inner plexiform layer, in which hypoxia-inducible factor 1α (HIF1α) has also been shown to be localized. In the current study, we examined whether hypoxia increases O-GlcNAcylation in retinal vascular cells under high glucose conditions and whether HIF1α activation is consistent with the response to and activation of O-GlcNAcylation in retinal lesions in diabetic retinopathy. In addition, the effects of O-GlcNAcylation on the blood‑retinal barrier were verified in vitro by the inhibition of O-GlcNAcylation. A time-dependent increase in the O-GlcNAcylation in bovine retinal vascular endothelial cells (BRVECs) was observed following incubation of the cells with high glucose medium (glucose 4.5 g/l) under hypoxic (1-3% O2) conditions. Hypoxia-induced BRVEC O-GlcNAcylation was not observed when the BRVECs were transfected with siRNA targeting O-GlcNAc transferase (OGT) or treated with alloxan (an OGT inhibitor) prior to exposure to high glucose. The increase in BRVEC O-GlcNAcylation induced by high glucose, as well as by thiamet G [an O-GlcNAcase (OGA) inhibitor] led to a reduction in occludin expression levels in vitro, which was prevented by treatment with OGT siRNA and alloxan. In conclusion, the current study demonstrates the relationship between O-GlcNAc glycosylation and hypoxia during diabetic retinopathy and that hyperglycemia induced O2 consumption activates HIF1α and O-GlcNAc modification protein in the same retinal layer. The reduced protein BRVEC O-GlcNAcylation levels exert protective effects on the blood-retinal barrier and thus represent a potential therapeutic target for the treatment of diabetic retinopathy.

View Figures

View References

1	Torres CR and Hart GW: Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc. J Biol Chem. 259:3308–3317. 1984.
2	Hart GW, Housley MP and Slawson C: Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins. Nature. 446:1017–1022. 2007. View Article : Google Scholar : PubMed/NCBI
3	Lima VV, Rigsby CS, Hardy DM, Webb RC and Tostes RC: O-GlcNAcylation: a novel post-translational mechanism to alter vascular cellular signaling in health and disease: focus on hypertension. J Am Soc Hypertens. 3:374–387. 2009. View Article : Google Scholar : PubMed/NCBI
4	Lima VV, Spitler K, Choi H, Webb RC and Tostes RC: O-GlcNAcylation and oxidation of proteins: is signalling in the cardiovascular system becoming sweeter? Clin Sci (Lond). 123:473–486. 2012. View Article : Google Scholar : PubMed/NCBI
5	Lima VV, Giachini FR, Carneiro FS, et al: Increased vascular O-GlcNAcylation augments reactivity to constrictor stimuli - VASOACTIVE PEPTIDE SYMPOSIUM. J Am Soc Hypertens. 2:410–417. 2008. View Article : Google Scholar : PubMed/NCBI
6	Kim do H, Seok YM, Kim IK, Lee IK, Jeong SY and Jeoung NH: Glucosamine increases vascular contraction through activation of RhoA/Rho kinase pathway in isolated rat aorta. BMB Rep. 44:415–420. 2011.
7	Grimm C and Willmann G: Hypoxia in the eye: a two-sided coin. High Alt Med Biol. 13:169–175. 2012. View Article : Google Scholar : PubMed/NCBI
8	Banumathi E, Haribalaganesh R, Babu SS, Kumar NS and Sangiliyandi G: High-yielding enzymatic method for isolation and culture of microvascular endothelial cells from bovine retinal blood vessels. Microvasc Res. 77:377–381. 2009. View Article : Google Scholar : PubMed/NCBI
9	Ali TK and El-Remessy AB: Diabetic retinopathy: current management and experimental therapeutic targets. Pharmacotherapy. 29:182–192. 2009. View Article : Google Scholar : PubMed/NCBI
10	Ruan HB, Singh JP, Li MD, Wu J and Yang X: Cracking the O-GlcNAc code in metabolism. Trends Endocrinol Metab. 24:301–309. 2013. View Article : Google Scholar : PubMed/NCBI
11	Jensen RV, Zachara NE, Nielsen PH, Kimose HH, Kristiansen SB and Botker HE: Impact of O-GlcNAc on cardioprotection by remote ischaemic preconditioning in non-diabetic and diabetic patients. Cardiovasc Res. 97:369–378. 2013. View Article : Google Scholar : PubMed/NCBI
12	Bennett CE, Johnsen VL, Shearer J and Belke DD: Exercise training mitigates aberrant cardiac protein O-GlcNAcylation in streptozotocin-induced diabetic mice. Life Sci. 92:657–663. 2013. View Article : Google Scholar : PubMed/NCBI
13	McLarty JL, Marsh SA and Chatham JC: Post-translational protein modification by O-linked N-acetyl-glucosamine: its role in mediating the adverse effects of diabetes on the heart. Life Sci. 92:621–627. 2013. View Article : Google Scholar : PubMed/NCBI
14	Gurel Z, Sieg KM, Shallow KD, Sorenson CM and Sheibani N: Retinal O-linked N-acetylglucosamine protein modifications: implications for postnatal retinal vascularization and the pathogenesis of diabetic retinopathy. Mol Vis. 19:1047–1059. 2013.
15	Zachara NE, Molina H, Wong KY, Pandey A and Hart GW: The dynamic stress-induced ‘O-GlcNAc-ome’ highlights functions for O-GlcNAc in regulating DNA damage/repair and other cellular pathways. Amino Acids. 40:793–808. 2011.
16	Tai TC, Wong-Faull DC, Claycomb R and Wong DL: Hypoxic stress-induced changes in adrenergic function: role of HIF1 alpha. J Neurochem. 109:513–524. 2009. View Article : Google Scholar : PubMed/NCBI
17	Witt KA, Mark KS, Huber J and Davis TP: Hypoxia-inducible factor and nuclear factor kappa-B activation in blood-brain barrier endothelium under hypoxic/reoxygenation stress. J Neurochem. 92:203–214. 2005. View Article : Google Scholar
18	Arden GB and Sivaprasad S: Hypoxia and oxidative stress in the causation of diabetic retinopathy. Curr Diabetes Rev. 7:291–304. 2011. View Article : Google Scholar : PubMed/NCBI
19	Li C, Chen P, Zhang J, et al: Enzyme-induced vitreolysis can alleviate the progression of diabetic retinopathy through the HIF-1alpha pathway. Invest Ophthalmol Vis Sci. 54:4964–4970. 2013. View Article : Google Scholar : PubMed/NCBI
20	Zachara NE, O’Donnell N, Cheung WD, Mercer JJ, Marth JD and Hart GW: Dynamic O-GlcNAc modification of nucleocytoplasmic proteins in response to stress. A survival response of mammalian cells. J Biol Chem. 279:30133–30142. 2004. View Article : Google Scholar : PubMed/NCBI
21	Arvanitis LD, Vassiou K, Kotrotsios A and Sgantzos MN: Hypoxia upregulates the expression of the O-linked N-acetylglucosamine containing epitope H in human ependymal cells. Pathol Res Pract. 207:91–96. 2011. View Article : Google Scholar : PubMed/NCBI
22	Ngoh GA, Watson LJ, Facundo HT, Dillmann W and Jones SP: Non-canonical glycosyltransferase modulates post-hypoxic cardiac myocyte death and mitochondrial permeability transition. J Mol Cell Cardiol. 45:313–325. 2008. View Article : Google Scholar : PubMed/NCBI
23	Ngoh GA, Facundo HT, Zafir A and Jones SP: O-GlcNAc signaling in the cardiovascular system. Circ Res. 107:171–185. 2010. View Article : Google Scholar : PubMed/NCBI
24	Araki E, Oyadomari S and Mori M: Endoplasmic reticulum stress and diabetes mellitus. Intern Med. 42:7–14. 2003. View Article : Google Scholar
25	Harding HP, Zeng H, Zhang Y, et al: Diabetes mellitus and exocrine pancreatic dysfunction in perk^−/− mice reveals a role for translational control in secretory cell survival. Mol Cell. 7:1153–1163. 2001. View Article : Google Scholar : PubMed/NCBI
26	Ozcan U, Cao Q, Yilmaz E, et al: Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science. 306:457–461. 2004. View Article : Google Scholar : PubMed/NCBI
27	Jones SP, Zachara NE, Ngoh GA, et al: Cardioprotection by N-acetylglucosamine linkage to cellular proteins. Circulation. 117:1172–1182. 2008. View Article : Google Scholar : PubMed/NCBI
28	Liu J, Marchase RB and Chatham JC: Increased O-GlcNAc levels during reperfusion lead to improved functional recovery and reduced calpain proteolysis. Am J Physiol Heart Circ Physiol. 293:H1391–H1399. 2007. View Article : Google Scholar : PubMed/NCBI
29	Ngoh GA, Facundo HT, Hamid T, Dillmann W, Zachara NE and Jones SP: Unique hexosaminidase reduces metabolic survival signal and sensitizes cardiac myocytes to hypoxia/reoxygenation injury. Circ Res. 104:41–49. 2009. View Article : Google Scholar : PubMed/NCBI
30	Champattanachai V, Marchase RB and Chatham JC: Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein O-GlcNAc and increased mitochondrial Bcl-2. Am J Physiol Cell Physiol. 294:C1509–C1520. 2008. View Article : Google Scholar : PubMed/NCBI
31	Ngoh GA, Hamid T, Prabhu SD and Jones SP: O-GlcNAc signaling attenuates ER stress-induced cardiomyocyte death. Am J Physiol Heart Circ Physiol. 297:H1711–H1719. 2009. View Article : Google Scholar : PubMed/NCBI
32	Hanover JA, Krause MW and Love DC: The hexosamine signaling pathway: O-GlcNAc cycling in feast or famine. Biochim Biophys Acta. 1800:80–95. 2010. View Article : Google Scholar : PubMed/NCBI
33	Guinez C, Mir AM, Leroy Y, Cacan R, Michalski JC and Lefebvre T: Hsp70-GlcNAc-binding activity is released by stress, proteasome inhibition, and protein misfolding. Biochem Biophys Res Commun. 361:414–420. 2007. View Article : Google Scholar : PubMed/NCBI
34	Kennedy A and Frank RN: The influence of glucose concentration and hypoxia on VEGF secretion by cultured retinal cells. Curr Eye Res. 36:168–177. 2011. View Article : Google Scholar : PubMed/NCBI
35	Loukovaara S, Koivunen P, Ingles M, Escobar J, Vento M and Andersson S: Elevated protein carbonyl and HIF-1alpha levels in eyes with proliferative diabetic retinopathy. Acta Ophthalmol. May 29–2013.(Epub ahead of print).
36	Yu DY and Cringle SJ: Oxygen distribution and consumption within the retina in vascularised and avascular retinas and in animal models of retinal disease. Prog Retin Eye Res. 20:175–208. 2001. View Article : Google Scholar : PubMed/NCBI
37	Yu DY, Cringle SJ, Yu PK and Su EN: Intraretinal oxygen distribution and consumption during retinal artery occlusion and graded hyperoxic ventilation in the rat. Invest Ophthalmol Vis Sci. 48:2290–2296. 2007. View Article : Google Scholar : PubMed/NCBI
38	Cringle SJ and Yu DY: A multi-layer model of retinal oxygen supply and consumption helps explain the muted rise in inner retinal PO(2) during systemic hyperoxia. Comp Biochem Physiol A Mol Integr Physiol. 132:61–66. 2002. View Article : Google Scholar
39	Yu DY, Cringle SJ and Su EN: Intraretinal oxygen distribution in the monkey retina and the response to systemic hyperoxia. Invest Ophthalmol Vis Sci. 46:4728–4733. 2005. View Article : Google Scholar : PubMed/NCBI
40	Sandercoe TM, Geller SF, Hendrickson AE, Stone J and Provis JM: VEGF expression by ganglion cells in central retina before formation of the foveal depression in monkey retina: evidence of developmental hypoxia. J Comp Neurol. 462:42–54. 2003. View Article : Google Scholar : PubMed/NCBI
41	Semenza GL: Hydroxylation of HIF-1: oxygen sensing at the molecular level. Physiology (Bethesda). 19:176–182. 2004. View Article : Google Scholar : PubMed/NCBI
42	Bensellam M, Duvillie B, Rybachuk G, et al: Glucose-induced O(2) consumption activates hypoxia inducible factors 1 and 2 in rat insulin-secreting pancreatic beta-cells. PLoS One. 7:e298072012. View Article : Google Scholar : PubMed/NCBI
43	Yang L, Tan P, Zhou W, et al: N-acetylcysteine protects against hypoxia mimetic-induced autophagy by targeting the HIF-1 alpha pathway in retinal ganglion cells. Cell Mol Neurobiol. 32:1275–1285. 2012. View Article : Google Scholar : PubMed/NCBI
44	Feldman GJ, Mullin JM and Ryan MP: Occludin: structure, function and regulation. Adv Drug Deliv Rev. 57:883–917. 2005. View Article : Google Scholar : PubMed/NCBI
45	Cummins PM: Occludin: one protein, many forms. Mol Cell Biol. 32:242–250. 2012. View Article : Google Scholar : PubMed/NCBI
46	Dorfel MJ and Huber O: Modulation of tight junction structure and function by kinases and phosphatases targeting occludin. J Biomed Biotechnol. 2012:8073562012. View Article : Google Scholar : PubMed/NCBI
47	Clarke H, Soler AP and Mullin JM: Protein kinase C activation leads to dephosphorylation of occludin and tight junction permeability increase in LLC-PK1 epithelial cell sheets. J Cell Sci. 113(Pt 18): 3187–3196. 2000.PubMed/NCBI
48	Simonovic I, Arpin M, Koutsouris A, Falk-Krzesinski HJ and Hecht G: Enteropathogenic Escherichia coli activates ezrin, which participates in disruption of tight junction barrier function. Infect Immun. 69:5679–5688. 2001.PubMed/NCBI
49	Butt AM, Feng D, Nasrullah I, et al: Computational identification of interplay between phosphorylation and O-beta-glycosylation of human occludin as potential mechanism to impair hepatitis C virus entry. Infect Genet Evol. 12:1235–1245. 2012. View Article : Google Scholar : PubMed/NCBI